retatrutide fda status for Weight Loss: TRIUMPH-1 Results, Cost, Insurance Retatrutide Weight Loss Results:Trial Data
Description
Retatrutide is not yet approved by Health Canada or any regulatory body as the compound remains in clinical trials
New GLP-1 medications are entering the market
10.1081/dmr-200033475 357
May 2020
PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization delays
Other secondary effects of GLP-1 RAs, such as gut microbiome shifts, may be asymptomatic and chronic with far-reaching physiologic potential
